SCHEMBL6748962

SCHEMBL6748962

CN1C(=O)CC(C)(C)c2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.45
MAPT P10636 6/20 0.44
LMNA P02545 4/20 0.44
HTT P42858 4/20 0.44
KDM4E B2RXH2 3/20 0.44
HCRTR1 O43613 1/20 0.44
BRPF1 P55201 1/20 0.43
TSHR P16473 2/20 0.42
ALDH1A1 P00352 2/20 0.41
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
BACE1 P56817 1/20 0.41
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
USP2 O75604 2/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC8 Q9BY41 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9591647 0.82 NOTUM (0.44) NOTUMMAPTLMNAHTTKDM4E
SCHEMBL10649314 0.80 NOTUM (0.44) NOTUMMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL23674965 0.80 NOTUM (0.44) NOTUMMAPTKDM4EALDH1A1SMN1; SMN2
SCHEMBL20335482 0.78 ALDH1A1 (0.47) NOTUMMAPTLMNAKDM4ETSHR
SCHEMBL9091776 0.77 RARA (0.51) NOTUMALDH1A1SMN1; SMN2
SCHEMBL14533938 0.77 OPRM1 (0.42) MAPTLMNAHTTKDM4ETSHR
SCHEMBL5736954 0.76 HDAC1 (0.47) MAPTLMNAALDH1A1SMN1; SMN2BACE1
SCHEMBL9144609 0.76 CASP2 (0.42) MAPTALDH1A1SMN1; SMN2BACE1MEN1
SCHEMBL27244161 0.76 HDAC3 (0.37) BACE1HDAC3HDAC4HDAC1HDAC2
SCHEMBL9593284 0.76 CYP19A1 (0.46) MAPTKDM4EGAABACE1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2670744-B1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR LUPIN LTD (IN) 2015-05-27 EP disclosed
US-20130310419-A1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR LUPIN LIMITED (IN) 2013-11-21 US disclosed
US-20040138230-A1 Heterocyclic substituted piperazines for the treatment of schizophrenia ANDREANA TONJA LYNN (US) 2004-07-15 US disclosed
US-5216148-A Treating, preventing neoplasms, dermatoses, aging of skin HOFFMANN-LA ROCHE INC. (US) 1993-06-01 US disclosed
EP-0504695-A1 New carboxamides, their preparation and pharmaceutical compositions containing them F. HOFFMANN-LA ROCHE AG (CH) 1992-09-23 EP disclosed
US-4788213-A TREATING ACNE AND PSORIASIS HOFFMAN-LA ROCHE INC. (US) 1988-11-29 US disclosed
US-4678793-A ACNE, PSORIASIS, ANTITUMOR HOFFMANN-LA ROCHE INC. (US) 1987-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138230-A1 Heterocyclic substituted piperazines for the treatment of schizophrenia CNR1, DRD2, CNR2 NOTUM 4017/4885MAPT 2926/4885LMNA 4160/4885
US-20130310419-A1 PYRROLE DERIVATIVES USED AS MODULATORS OF ALPHA7 NACHR CHRNA7, CHRNE, CHRNA5 NOTUM 1019/4885MAPT 575/4885LMNA 3535/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.